-transparent.png){kind=logo}
[Dysplasia and laryngeal carcinoma in situ]. 2012
Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde & Plastische Operationen, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23583, Lübeck, Deutschland. ursula.schroeder@uksh.de
Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.
Related Publications
U Schroeder, and
M P E Gebhard, and
B Wollenberg
April 1960,
Arizona medicine,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
April 1957,
Ceskoslovenska otolaryngologie,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
February 1971,
Minerva ginecologica,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
March 2017,
Surgical pathology clinics,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
May 2012,
Pneumologie (Stuttgart, Germany),
U Schroeder, and
M P E Gebhard, and
B Wollenberg
October 1981,
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
June 1962,
Journal of the Mississippi State Medical Association,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
September 2011,
Journal francais d'ophtalmologie,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
January 1984,
CA: a cancer journal for clinicians,
U Schroeder, and
M P E Gebhard, and
B Wollenberg
June 2000,
Acta oto-laryngologica,
